• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国南方从东南亚和非洲输入的 Kelch 13 多态性的遗传多样性调查与评估

Investigation and Evaluation of Genetic Diversity of Kelch 13 Polymorphisms Imported From Southeast Asia and Africa in Southern China.

作者信息

Feng Jun, Kong Xiangli, Xu Dongmei, Yan He, Zhou Hongning, Tu Hong, Lin Kangming

机构信息

Chinese Center for Disease Control and Prevention, National Institute of Parasitic Diseases, Shanghai, China.

Key Laboratory of Parasite and Vector Biology, Ministry of Health, Shanghai, China.

出版信息

Front Public Health. 2019 Apr 24;7:95. doi: 10.3389/fpubh.2019.00095. eCollection 2019.

DOI:10.3389/fpubh.2019.00095
PMID:31069209
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6491575/
Abstract

In this study, we aimed to analyse the genetic diversity Kelch 13 (K13) propeller allele of the isolates mainly imported from Southeast Asia and Africa in southern China, including the provinces of Yunnan and Guangxi. At enrolment, we collected blood samples from patients with confirmed cases of malaria infection between January 2012 and December 2017, for analysis. Individual patient information was obtained via a malaria surveillance system. The malaria infections and K13 mutations were diagnosed by using a nested polymerase chain reaction (PCR) method. The K13 mutations were identified in 283 isolates from 18 counties in Yunnan and 22 counties in Guangxi. Of Forty-six isolates (46/283, 16.3%) that harbored K13 mutant alleles were detected: 26.8% in Yunnan (33/123) and 8.1% in Guangxi (13/160). A total of 18 different K13 mutations were detected. Only the F446I mutation was detected in Yunnan isolates, and F446I was more frequent (20/46, 43.5%) than other alleles. Further, the temporal distribution of the F446I mutation ratio from 2012 to 2015 exhibited no significant difference in Yunnan Province (2012, 2/13, 15.4%; 2013, 7/40, 17.5%; 2014, 7/33, 21.2%; 2015, 4/37, 10.8%, = 0.121). A578S allele was the main K13 mutation (5/283, 1.8%) from Africa. The K13 mutants were present in 33.3% of indigenous isolates, 27.4% of isolates from Southeast Asia, and 7.9% of isolates from Africa. The analysis of 10 neutral microsatellite loci of 60 isolates showed that at the TAA109 locus, the expected heterozygosity of F446I ( = 0.112 ± 0.007) was much lower than that of wild type and other mutation types in Myanmar isolates. With respect to geographic distribution, TAA109 also exhibited a significant difference between isolates from Southeast Asia ( = 0.139 ± 0.012) and those from Africa ( = 0.603 ± 0.044). The present findings on the geographic diversity of K13 mutant alleles in may provide a basis for routine molecular surveillance and risk assessment, to monitor artemisinin resistance (ART) in China. Our results will be helpful for enriching the artemisinin resistance database in China during the elimination and post-elimination phases.

摘要

在本研究中,我们旨在分析主要从中国南方的东南亚和非洲输入的分离株中,凯尔希13(K13)螺旋桨等位基因的遗传多样性,这些地区包括云南省和广西壮族自治区。在入组时,我们收集了2012年1月至2017年12月期间确诊的疟疾感染患者的血样进行分析。通过疟疾监测系统获取个体患者信息。采用巢式聚合酶链反应(PCR)方法诊断疟疾感染和K13突变。在来自云南18个县和广西22个县的283株分离株中鉴定出K13突变。在检测到的携带K13突变等位基因的46株分离株中(46/283,16.3%):云南为26.8%(33/123),广西为8.1%(13/160)。共检测到18种不同的K13突变。在云南分离株中仅检测到F446I突变,且F446I比其他等位基因更常见(20/46,43.5%)。此外,2012年至2015年云南省F446I突变率的时间分布无显著差异(2012年,2/13,15.4%;2013年,7/40,17.5%;2014年,7/33,21.2%;2015年,4/37,10.8%,P = 0.121)。A578S等位基因是来自非洲的主要K13突变(5/283,1.8%)。K13突变体存在于33.3%的本地分离株、27.4%的东南亚分离株和7.9%的非洲分离株中。对60株分离株的10个中性微卫星位点的分析表明,在TAA109位点,缅甸分离株中F446I的预期杂合度(P = 0.112±0.007)远低于野生型和其他突变类型。在地理分布方面,东南亚分离株(P = 0.139±0.012)和非洲分离株(P = 0.603±0.044)的TAA109也存在显著差异。本研究关于K13突变等位基因地理多样性的发现可能为中国常规分子监测和风险评估提供依据,以监测青蒿素耐药性(ART)。我们的结果将有助于在消除和消除后阶段丰富中国的青蒿素耐药性数据库。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e416/6491575/8e4daebd39a1/fpubh-07-00095-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e416/6491575/7c4de87d1782/fpubh-07-00095-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e416/6491575/8e4daebd39a1/fpubh-07-00095-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e416/6491575/7c4de87d1782/fpubh-07-00095-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e416/6491575/8e4daebd39a1/fpubh-07-00095-g0002.jpg

相似文献

1
Investigation and Evaluation of Genetic Diversity of Kelch 13 Polymorphisms Imported From Southeast Asia and Africa in Southern China.中国南方从东南亚和非洲输入的 Kelch 13 多态性的遗传多样性调查与评估
Front Public Health. 2019 Apr 24;7:95. doi: 10.3389/fpubh.2019.00095. eCollection 2019.
2
[Polymorphism Analysis of Plasmodium falciparum K13 Gene Kelch Domain Associated with Resistance to Artemisinin in Yunnan Province].[云南省恶性疟原虫K13基因 Kelch 结构域与青蒿素抗性相关的多态性分析]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2016 Aug;34(4):339-45.
3
Genetic association between the Pfk13 gene mutation and artemisinin resistance phenotype in Plasmodium falciparum isolates from Yunnan Province, China.在中国云南省的疟原虫分离株中 Pfk13 基因突变与青蒿素耐药表型的遗传关联。
Malar J. 2018 Dec 18;17(1):478. doi: 10.1186/s12936-018-2619-4.
4
Molecular surveillance of Pfcrt and k13 propeller polymorphisms of imported Plasmodium falciparum cases to Zhejiang Province, China between 2016 and 2018.2016 年至 2018 年间,中国浙江省输入性疟疾病例中 PfCRT 和 K13 桨叶多态性的分子监测。
Malar J. 2020 Feb 4;19(1):59. doi: 10.1186/s12936-020-3140-0.
5
K13-propeller gene polymorphisms of Plasmodium falciparum and the therapeutic effect of artesunate among migrant workers returning to Guangxi, China (2014-2017).中国广西流动人口疟原虫 K13-螺旋桨基因突变与青蒿琥酯疗效(2014-2017 年)。
Malar J. 2019 Oct 16;18(1):349. doi: 10.1186/s12936-019-2984-7.
6
Polymorphism analysis of propeller domain of k13 gene in Plasmodium ovale curtisi and Plasmodium ovale wallikeri isolates original infection from Myanmar and Africa in Yunnan Province, China.中国云南省从缅甸和非洲原代感染的卵形疟原虫 curtisi 和卵形疟原虫 wallikeri 分离株中 k13 基因的桨叶结构域多态性分析。
Malar J. 2020 Jul 13;19(1):246. doi: 10.1186/s12936-020-03317-2.
7
Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013.2012 - 2013年从塞内加尔达喀尔分离出的恶性疟原虫中k13基因的有限多态性
Malar J. 2014 Dec 4;13:472. doi: 10.1186/1475-2875-13-472.
8
Polymorphisms of pfcrt, pfmdr1, and K13-propeller genes in imported falciparum malaria isolates from Africa in Guizhou province, China.贵州省从非洲输入的恶性疟原虫分离株中 pfcrt、pfmdr1 和 K13-推进器基因的多态性。
BMC Infect Dis. 2020 Jul 16;20(1):513. doi: 10.1186/s12879-020-05228-8.
9
Prevalence of K13-propeller polymorphisms in Plasmodium falciparum from China-Myanmar border in 2007-2012.2007 - 2012年中国-缅甸边境恶性疟原虫K13螺旋桨多态性的流行情况。
Malar J. 2015 Apr 18;14:168. doi: 10.1186/s12936-015-0672-9.
10
Limited artemisinin resistance-associated polymorphisms in Plasmodium falciparum K13-propeller and PfATPase6 gene isolated from Bioko Island, Equatorial Guinea.从赤道几内亚比奥科岛分离出的恶性疟原虫K13螺旋桨蛋白和PfATPase6基因中与青蒿素耐药性相关的多态性有限。
Int J Parasitol Drugs Drug Resist. 2016 Jan 12;6(1):54-59. doi: 10.1016/j.ijpddr.2015.11.002. eCollection 2016 Apr.

引用本文的文献

1
Advancing artemisinin resistance monitoring using a high sensitivity ddPCR assay for Pfkelch13 mutation detection in Asia.利用高灵敏度数字滴度PCR检测法推进亚洲地区恶性疟原虫Kelch13基因突变的青蒿素耐药性监测。
Sci Rep. 2025 Feb 10;15(1):4869. doi: 10.1038/s41598-025-86630-7.
2
A review of malaria molecular markers for drug resistance in and in China.中国和东南亚疟疾耐药性分子标志物的研究进展。
Front Cell Infect Microbiol. 2023 May 9;13:1167220. doi: 10.3389/fcimb.2023.1167220. eCollection 2023.
3
Molecular surveillance of artemisinin resistance-related Pfk13 and pfcrt polymorphisms in imported Plasmodium falciparum isolates reported in eastern China from 2015 to 2019.

本文引用的文献

1
Ready for malaria elimination: zero indigenous case reported in the People's Republic of China.做好消除疟疾准备:中国报告本土疟疾病例清零。
Malar J. 2018 Aug 29;17(1):315. doi: 10.1186/s12936-018-2444-9.
2
[Polymorphism Analysis of Plasmodium falciparum K13 Gene Kelch Domain Associated with Resistance to Artemisinin in Yunnan Province].[云南省恶性疟原虫K13基因 Kelch 结构域与青蒿素抗性相关的多态性分析]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2016 Aug;34(4):339-45.
3
Artemisinin-Resistant Plasmodium falciparum with High Survival Rates, Uganda, 2014-2016.
2015 年至 2019 年期间,中国东部报告的输入性恶性疟原虫分离株中,与青蒿素耐药相关的 Pfk13 和 pfcrt 多态性的分子监测。
Malar J. 2022 Dec 4;21(1):369. doi: 10.1186/s12936-022-04398-x.
4
Structural Modelling Prediction of Recombinant K13-F446I and K13-C580Y Gene by AlphaFold Method and Heterologous Expression in 9 Cells.利用AlphaFold方法对重组K13-F446I和K13-C580Y基因进行结构建模预测及在9细胞中的异源表达
Pathogens. 2022 Oct 31;11(11):1271. doi: 10.3390/pathogens11111271.
5
Making data map-worthy-enhancing routine malaria data to support surveillance and mapping of Plasmodium falciparum anti-malarial resistance in a pre-elimination sub-Saharan African setting: a molecular and spatiotemporal epidemiology study.使数据具有制图价值——增强常规疟疾数据,以支持在撒哈拉以南非洲消除前地区监测和绘制恶性疟原虫抗疟药耐药性的地图:一项分子和时空流行病学研究。
Malar J. 2022 Jun 29;21(1):207. doi: 10.1186/s12936-022-04224-4.
6
Asymptomatic malaria infection at the China-Vietnam border: Knowledge and implications for the cross-border migrant population during the COVID-19 pandemic.中越边境无症状疟疾感染:COVID-19 大流行期间对跨境移民人群的认知及影响。
Travel Med Infect Dis. 2022 May-Jun;47:102307. doi: 10.1016/j.tmaid.2022.102307. Epub 2022 Mar 8.
7
High Frequency Mutations in and of in Response to Sulfadoxine-Pyrimethamine: A Cross-Sectional Survey in Returning Chinese Migrants From Africa.磺胺多辛-乙胺嘧啶治疗应答中 基因和 基因高频突变:来自非洲返回中国移民的横断面调查。
Front Cell Infect Microbiol. 2021 Sep 8;11:673194. doi: 10.3389/fcimb.2021.673194. eCollection 2021.
8
Characterization of , , , , and in Travelers Returning from Africa with Plasmodium falciparum Infections Reported in China from 2014 to 2018.2014 年至 2018 年中国报告从非洲感染恶性疟原虫返回旅行者中 、 、 、 和 的特征。
Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0271720. doi: 10.1128/AAC.02717-20.
9
Drug resistance markers within an evolving efficacy of anti-malarial drugs in Cameroon: a systematic review and meta-analysis (1998-2020).抗疟药在喀麦隆疗效演变中的耐药标志物:系统评价和荟萃分析(1998-2020 年)。
Malar J. 2021 Jan 9;20(1):32. doi: 10.1186/s12936-020-03543-8.
10
Efficacy of Artemether-Lumefantrine on various and genes isolated in Ghana.蒿甲醚-本芴醇对在加纳分离出的各种[具体内容缺失]和基因的疗效。
Parasite Epidemiol Control. 2020 Oct 26;11:e00190. doi: 10.1016/j.parepi.2020.e00190. eCollection 2020 Nov.
2014-2016 年,在高生存率的情况下,乌干达出现青蒿素耐药疟原虫。
Emerg Infect Dis. 2018 Apr;24(4):718-726. doi: 10.3201/eid2404.170141.
4
Mapping transmission foci to eliminate malaria in the People's Republic of China, 2010-2015: a retrospective analysis.2010-2015 年中国消除疟疾传播重点地区的绘制:回顾性分析。
BMC Infect Dis. 2018 Mar 7;18(1):115. doi: 10.1186/s12879-018-3018-8.
5
Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015.2015 年安哥拉三省无并发症恶性疟原虫感染患者中青蒿素和咯萘啶耐药相关分子标志物的流行情况。
Malar J. 2018 Feb 20;17(1):84. doi: 10.1186/s12936-018-2233-5.
6
Surveillance of Antimalarial Resistance Molecular Markers in Imported Malaria Cases in Anhui, China, 2012-2016.2012-2016 年中国安徽输入性疟疾病例中抗疟药耐药分子标记物的监测
Am J Trop Med Hyg. 2018 Apr;98(4):1132-1136. doi: 10.4269/ajtmh.17-0864. Epub 2018 Feb 8.
7
Polymorphisms of Plasmodium falciparum k13-propeller gene among migrant workers returning to Henan Province, China from Africa.从非洲返回中国河南省的农民工中恶性疟原虫k13螺旋桨基因的多态性
BMC Infect Dis. 2017 Aug 10;17(1):560. doi: 10.1186/s12879-017-2634-z.
8
Updates on k13 mutant alleles for artemisinin resistance in Plasmodium falciparum.恶性疟原虫青蒿素耐药性 K13 突变等位基因的最新研究进展。
J Microbiol Immunol Infect. 2018 Apr;51(2):159-165. doi: 10.1016/j.jmii.2017.06.009. Epub 2017 Jun 29.
9
Therapeutic efficacy and artemisinin resistance in northern Myanmar: evidence from in vivo and molecular marker studies.缅甸北部的治疗效果与青蒿素耐药性:来自体内研究和分子标记研究的证据
Malar J. 2017 Apr 7;16(1):143. doi: 10.1186/s12936-017-1775-2.
10
Emergence of Indigenous Artemisinin-Resistant Plasmodium falciparum in Africa.非洲出现对青蒿素耐药的恶性疟原虫。
N Engl J Med. 2017 Mar 9;376(10):991-3. doi: 10.1056/NEJMc1612765. Epub 2017 Feb 22.